Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Beijing Tong Ren Tang Chinese Medicine Company Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
18.00
Strong
WeakModerateStrong
P/B Ratio
1.69
Strong
WeakModerateStrong
Earnings Yield
5.61%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
9.48%
Weak
WeakModerateStrong
Operating Margin
31.20%
Strong
WeakModerateStrong
Net Profit Margin
26.25%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-87.91%
Weak
WeakModerateStrong
Net Income Growth
-20.58%
Weak
WeakModerateStrong
EPS Growth
-89.91%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
19.65
Strong
WeakModerateStrong
Quick Ratio
13.16
Strong
WeakModerateStrong
Asset Turnover
0.32x
Weak
WeakModerateStrong
Inventory Turnover
0.44x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
11.68%
Strong
WeakModerateStrong
EV / Free Cash Flow
6.02x
Strong
WeakModerateStrong
Net Debt / EBITDA
-4.24x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.069
Strong
WeakModerateStrong
Return on Invested Capital
8.66%
Weak
WeakModerateStrong
Cash Conversion Cycle
895.31 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BJTRF.
View Financial Statements